Skip to main content

Table 1 Baseline characteristics of study population according to treatments

From: Urinary tract infection after radiation therapy or radical prostatectomy on the prognosis of patients with prostate cancer: a population-based study

 

Total

RT

RP Open/laparoscopic

RP Robot-assisted

p-value

 

ANOVAa

Pairwiseb

Characteristics

(N = 28,887)

(N = 5,094)

(N = 12,740)

(N = 11,053)

RT vs. Open/laparoscopic

RT vs. Robot-assisted

Robot-assisted vs. Open/laparoscopic

Age at PC diagnosis (years), mean (SD)

67.4 (7.3)

70.35 (7.9)

67.22 (6.1)

66.26 (7.9)

< 0.001

< 0.001

< 0.001

< 0.001

Age Group at PC diagnosis

    

< 0.001

< 0.001

< 0.001

< 0.001

 - < 75

24,363 (84.3)

3,377 (66.3)

11,471 (90.0)

9,515 (86.1)

    

 - ≥ 75

4,524 (15.7)

1,717 (33.7)

1,269 (10.0)

1,538 (13.9)

    

Year of PC diagnosis

    

< 0.001

< 0.001

< 0.001

< 0.001

 - 2007–2009

6,516 (22.6)

1,323 (26.0)

3,579 (28.1)

1,614 (14.6)

< 0.001

0.006

< 0.001

< 0.001

 - 2010–2012

9,798 (33.9)

1,614 (31.7)

4,457 (35.0)

3,727 (33.7)

< 0.001

< 0.001

0.299

0.099

 - 2013–2016

12,573 (43.5)

2,157 (42.3)

4,704 (36.9)

5,712 (51.7)

< 0.001

< 0.001

< 0.001

< 0.001

UTI

    

< 0.001

< 0.001

0.226

< 0.001

 - NO

22,569 (78.1)

4,164 (81.7)

9,497 (74.5)

8,908 (80.6)

    

 - YES

6,318 (21.9)

930 (18.3)

3,243 (25.5)

2,145 (19.4)

    

ADT

    

< 0.001

< 0.001

< 0.001

< 0.001

 - NO

21,806 (75.5)

1,876 (36.8)

10,919 (85.7)

9,011 (81.5)

    

 - YES

7,081 (24.5)

3,218 (63.2)

1,821 (14.3)

2,042 (18.5)

    

Anticholinergic drugs

    

< 0.001

< 0.001

< 0.001

< 0.001

 - NO

17,759 (61.5)

4,297 (84.4)

6,897 (35.8)

6,565 (44.4)

    

 - YES

11,128 (38.5)

797 (15.6)

5,843 (64.2)

4,488 (55.6)

    

CCI scores

    

0.001

0.909

0.735

0.898

 - 0–1

6,718 (23.3)

1,255 (24.6)

2,972 (23.3)

2,491 (22.5)

0.013

0.148

0.009

0.320

 - 2–3

10,089 (34.9)

1,670 (32.8)

4,441 (34.9)

3,978 (36.0)

< 0.001

0.023

< 0.001

0.161

 - ≥ 4

12,080 (41.8)

2,169 (42.6)

5,327 (41.8)

4,584 (41.5)

0.416

0.617

0.381

0.856

Diabetes

    

< 0.001

0.039

0.181

 < 0.001

 - NO

18,307 (63.4)

3,244 (63.7)

7,865 (61.7)

7,198 (65.1)

    

 - YES

10,580 (36.6)

1,850 (36.3)

4,875 (38.3)

3,855 (34.9)

    

Renal disease

    

< 0.001

0.002

< 0.001

0.005

 - NO

27,270 (94.4)

4,737 (93.0)

12,010 (94.3)

10,523 (95.2)

    

 - YES

1,617 (5.6)

357 (7.0)

730 (5.7)

530 (4.8)

    

Hypertension

    

< 0.001

< 0.001

< 0.001

< 0.001

 - NO

23,522 (81.4)

4,003 (78.6)

10,334 (81.1)

9,185 (83.1)

    

 - YES

5,365 (18.6)

1,091 (21.4)

2,406 (18.9)

1,868 (16.9)

    
  1. Values are presented as numbers (%) or means (standard deviations)
  2. Abbreviations: PC Prostate cancer, SD Standard deviation, UTI Urinary tract infection, ADT Androgen deprivation therapy, CCI Charlson Comorbidity Index
  3. aANOVA
  4. bPairwise t-test with Tukey correction
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us